Atlas Trials

PD-L1 Positive

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch PD-L1 Positive

RecordFirmDate
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (NCT05382286)Gilead Sciences2022-07-25
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer (NCT02955290)Roswell Park Cancer Institute2016-12-22

Track PD-L1 Positive automatically

Every clearance here is in the API, with alerts when new ones post.